Copyright Reports & Markets. All rights reserved.

Global Orthostatic Hypotension Drugs Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Orthostatic Hypotension Drugs Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Midodrine
      • 1.4.3 Northera (droxidopa)
      • 1.4.4 Fludrocortisone
      • 1.4.5 Other Drugs
    • 1.5 Market by Application
      • 1.5.1 Global Orthostatic Hypotension Drugs Market Share by Application (2019-2025)
      • 1.5.2 Hospital
      • 1.5.3 Medical Research Institute
      • 1.5.4 Clinic
      • 1.5.5 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Orthostatic Hypotension Drugs Market Size
    • 2.2 Orthostatic Hypotension Drugs Growth Trends by Regions
      • 2.2.1 Orthostatic Hypotension Drugs Market Size by Regions (2019-2025)
      • 2.2.2 Orthostatic Hypotension Drugs Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Orthostatic Hypotension Drugs Market Size by by Players
      • 3.1.1 Global Orthostatic Hypotension Drugs Revenue by by Players (2014-2019)
      • 3.1.2 Global Orthostatic Hypotension Drugs Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Orthostatic Hypotension Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.2 Orthostatic Hypotension Drugs Key Players Head office and Area Served
    • 3.3 Key Players Orthostatic Hypotension Drugs Product/Solution/Service
    • 3.4 Date of Enter into Orthostatic Hypotension Drugs Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Orthostatic Hypotension Drugs Market Size by Type (2014-2019)
    • 4.2 Global Orthostatic Hypotension Drugs Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Orthostatic Hypotension Drugs Market Size (2014-2019)
    • 5.2 Orthostatic Hypotension Drugs Key Players in North America
    • 5.3 North America Orthostatic Hypotension Drugs Market Size by Type
    • 5.4 North America Orthostatic Hypotension Drugs Market Size by Application

    6 Europe

    • 6.1 Europe Orthostatic Hypotension Drugs Market Size (2014-2019)
    • 6.2 Orthostatic Hypotension Drugs Key Players in Europe
    • 6.3 Europe Orthostatic Hypotension Drugs Market Size by Type
    • 6.4 Europe Orthostatic Hypotension Drugs Market Size by Application

    7 China

    • 7.1 China Orthostatic Hypotension Drugs Market Size (2014-2019)
    • 7.2 Orthostatic Hypotension Drugs Key Players in China
    • 7.3 China Orthostatic Hypotension Drugs Market Size by Type
    • 7.4 China Orthostatic Hypotension Drugs Market Size by Application

    8 Japan

    • 8.1 Japan Orthostatic Hypotension Drugs Market Size (2014-2019)
    • 8.2 Orthostatic Hypotension Drugs Key Players in Japan
    • 8.3 Japan Orthostatic Hypotension Drugs Market Size by Type
    • 8.4 Japan Orthostatic Hypotension Drugs Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Orthostatic Hypotension Drugs Market Size (2014-2019)
    • 9.2 Orthostatic Hypotension Drugs Key Players in Southeast Asia
    • 9.3 Southeast Asia Orthostatic Hypotension Drugs Market Size by Type
    • 9.4 Southeast Asia Orthostatic Hypotension Drugs Market Size by Application

    10 India

    • 10.1 India Orthostatic Hypotension Drugs Market Size (2014-2019)
    • 10.2 Orthostatic Hypotension Drugs Key Players in India
    • 10.3 India Orthostatic Hypotension Drugs Market Size by Type
    • 10.4 India Orthostatic Hypotension Drugs Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Orthostatic Hypotension Drugs Market Size (2014-2019)
    • 11.2 Orthostatic Hypotension Drugs Key Players in Central & South America
    • 11.3 Central & South America Orthostatic Hypotension Drugs Market Size by Type
    • 11.4 Central & South America Orthostatic Hypotension Drugs Market Size by Application

    12 International Players Profiles

    • 12.1 Amneal Pharmaceuticals Inc.
      • 12.1.1 Amneal Pharmaceuticals Inc. Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Orthostatic Hypotension Drugs Introduction
      • 12.1.4 Amneal Pharmaceuticals Inc. Revenue in Orthostatic Hypotension Drugs Business (2014-2019))
      • 12.1.5 Amneal Pharmaceuticals Inc. Recent Development
    • 12.2 H. Lundbeck AS
      • 12.2.1 H. Lundbeck AS Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Orthostatic Hypotension Drugs Introduction
      • 12.2.4 H. Lundbeck AS Revenue in Orthostatic Hypotension Drugs Business (2014-2019)
      • 12.2.5 H. Lundbeck AS Recent Development
    • 12.3 Mylan NV
      • 12.3.1 Mylan NV Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Orthostatic Hypotension Drugs Introduction
      • 12.3.4 Mylan NV Revenue in Orthostatic Hypotension Drugs Business (2014-2019)
      • 12.3.5 Mylan NV Recent Development
    • 12.4 Novartis AG
      • 12.4.1 Novartis AG Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Orthostatic Hypotension Drugs Introduction
      • 12.4.4 Novartis AG Revenue in Orthostatic Hypotension Drugs Business (2014-2019)
      • 12.4.5 Novartis AG Recent Development
    • 12.5 Pfizer Inc.
      • 12.5.1 Pfizer Inc. Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Orthostatic Hypotension Drugs Introduction
      • 12.5.4 Pfizer Inc. Revenue in Orthostatic Hypotension Drugs Business (2014-2019)
      • 12.5.5 Pfizer Inc. Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      The increasing prevalence of chronic diseases will also contribute to the growth of the OH drugs market. Orthostatic hypotension is associated with various neurodegenerative diseases, cardiovascular diseases, and diabetes.
      Orthostatic hypotension is difficult to treat with single-drug therapy because orthostatic stress varies as per the circumstances during the day. Moreover, most of the OH drugs are used to improve postural symptoms, standing time, and function instead of achieving upright normotension that may cause supine hypertension. These factors have boosted the use of a combination of various drugs, such as midodrine and fludrocortisone, midodrine and pyridostigmine, or midodrine and octreotide, for the treatment of symptomatic OH.
      In 2018, the global Orthostatic Hypotension Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Orthostatic Hypotension Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Orthostatic Hypotension Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Amneal Pharmaceuticals Inc.
      H. Lundbeck AS
      Mylan NV
      Novartis AG
      Pfizer Inc.
      ...

      Market segment by Type, the product can be split into
      Midodrine
      Northera (droxidopa)
      Fludrocortisone
      Other Drugs

      Market segment by Application, split into
      Hospital
      Medical Research Institute
      Clinic
      Other

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Orthostatic Hypotension Drugs status, future forecast, growth opportunity, key market and key players.
      To present the Orthostatic Hypotension Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Orthostatic Hypotension Drugs are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now